312 related articles for article (PubMed ID: 17978809)
1. In vitro activity of kaempferol isolated from the Impatiens balsamina alone and in combination with erythromycin or clindamycin against Propionibacterium acnes.
Lim YH; Kim IH; Seo JJ
J Microbiol; 2007 Oct; 45(5):473-7. PubMed ID: 17978809
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the antibacterial activity of rhapontigenin produced from rhapontin by biotransformation against Propionibacterium acnes.
Kim JK; Kim N; Lim YH
J Microbiol Biotechnol; 2010 Jan; 20(1):82-7. PubMed ID: 20134237
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial susceptibility and genetic characteristics of Propionibacterium acnes isolated from patients with acne.
Schafer F; Fich F; Lam M; Gárate C; Wozniak A; Garcia P
Int J Dermatol; 2013 Apr; 52(4):418-25. PubMed ID: 23432195
[TBL] [Abstract][Full Text] [Related]
4. Antibiotic sensitivity of comedonal Propionibacterium acnes.
Guin JD; Huber DS; Gielerak PL
Acta Derm Venereol; 1979; 59(6):552-54. PubMed ID: 94223
[TBL] [Abstract][Full Text] [Related]
5. Antibiotic susceptibility of Propionibacterium acnes isolated from acne vulgaris in Korea.
Song M; Seo SH; Ko HC; Oh CK; Kwon KS; Chang CL; Kim MB
J Dermatol; 2011 Jul; 38(7):667-73. PubMed ID: 21352337
[TBL] [Abstract][Full Text] [Related]
6. Nasal antibiotic-resistant Propionibacterium acnes carriage in acne vulgaris patients in Turkey.
Ergin C; Ergin S; Kaleli I; Kaçar N; Sengül M; Erdoğan BS
J Dermatol; 2006 Dec; 33(12):899-901. PubMed ID: 17169100
[No Abstract] [Full Text] [Related]
7. Inhibition of lipase activity in antibiotic-resistant propionibacterium acnes strains.
Gloor M; Wasik B; Becker A; Höffler U
Dermatology; 2002; 205(3):260-4. PubMed ID: 12399674
[TBL] [Abstract][Full Text] [Related]
8. In vivo antibacterial effects of tretinoin-clindamycin and clindamycin alone on Propionibacterium acnes with varying clindamycin minimum inhibitory.
Leyden JJ
J Drugs Dermatol; 2012 Dec; 11(12):1434-8. PubMed ID: 23377513
[TBL] [Abstract][Full Text] [Related]
9. Effect of zinc gluconate on propionibacterium acnes resistance to erythromycin in patients with inflammatory acne: in vitro and in vivo study.
Dreno B; Foulc P; Reynaud A; Moyse D; Habert H; Richet H
Eur J Dermatol; 2005; 15(3):152-5. PubMed ID: 15908296
[TBL] [Abstract][Full Text] [Related]
10. [In vitro sensitivity of Corynebacterium acnes (Propionibacterium acnes) to meclocycline, clindamycin, erythromycin and neomycin].
Lucca L; Vittadini G
G Ital Chemioter; 1979; 26(1-2):203-6. PubMed ID: 554810
[No Abstract] [Full Text] [Related]
11. Resistance of propionibacteria to antibiotics used in the treatment of acne.
Brown JM; Poston SM
J Med Microbiol; 1983 Aug; 16(3):271-80. PubMed ID: 6224016
[TBL] [Abstract][Full Text] [Related]
12. In vitro activities of cefotaxime, vancomycin, quinupristin/dalfopristin, linezolid and other antibiotics alone and in combination against Propionibacterium acnes isolates from central nervous system infections.
Mory F; Fougnot S; Rabaud C; Schuhmacher H; Lozniewski A
J Antimicrob Chemother; 2005 Feb; 55(2):265-8. PubMed ID: 15590714
[TBL] [Abstract][Full Text] [Related]
13. Antibiotic-resistant Propionibacterium acnes among acne patients in a regional skin centre in Hong Kong.
Luk NM; Hui M; Lee HC; Fu LH; Liu ZH; Lam LY; Eastel M; Chan YK; Tang LS; Cheng TS; Siu FY; Ng SC; Lai YK; Ho KM
J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):31-6. PubMed ID: 22103749
[TBL] [Abstract][Full Text] [Related]
14. Anti-inflammatory effects of erythromycin and tetracycline on Propionibacterium acnes induced production of chemotactic factors and reactive oxygen species by human neutrophils.
Jain A; Sangal L; Basal E; Kaushal GP; Agarwal SK
Dermatol Online J; 2002 Oct; 8(2):2. PubMed ID: 12546757
[TBL] [Abstract][Full Text] [Related]
15. In vitro antibiotic susceptibility patterns of Propionibacterium acnes isolated from acne patients: an Egyptian university hospital-based study.
Abdel Fattah NS; Darwish YW
J Eur Acad Dermatol Venereol; 2013 Dec; 27(12):1546-51. PubMed ID: 23279041
[TBL] [Abstract][Full Text] [Related]
16. Topically applied antibiotics in acne vulgaris: clinical response and suppression of Corynebacterium acnes in open comedones.
Resh W; Stoughton RB
Arch Dermatol; 1976 Feb; 112(2):182-4. PubMed ID: 134675
[TBL] [Abstract][Full Text] [Related]
17. A Myrtus communis extract enriched in myrtucummulones and ursolic acid reduces resistance of Propionibacterium acnes biofilms to antibiotics used in acne vulgaris.
Feuillolay C; Pecastaings S; Le Gac C; Fiorini-Puybaret C; Luc J; Joulia P; Roques C
Phytomedicine; 2016 Mar; 23(3):307-15. PubMed ID: 26969384
[TBL] [Abstract][Full Text] [Related]
18. Effects of subminimal inhibitory concentrations of erythromycin, tetracycline, clindamycin, and minocycline on the neutrophil chemotactic factor production in Propionibacterium acnes biotypes 1-5.
Akamatsu H; Nishijima S; Takahashi M; Ushijima T; Asada Y
J Dermatol; 1991 May; 18(5):247-51. PubMed ID: 1834712
[TBL] [Abstract][Full Text] [Related]
19. Phenotypic and genotypic characterization of antibiotic-resistant Propionibacterium acnes isolated from acne patients attending dermatology clinics in Europe, the U.S.A., Japan and Australia.
Ross JI; Snelling AM; Eady EA; Cove JH; Cunliffe WJ; Leyden JJ; Collignon P; Dréno B; Reynaud A; Fluhr J; Oshima S
Br J Dermatol; 2001 Feb; 144(2):339-46. PubMed ID: 11251569
[TBL] [Abstract][Full Text] [Related]
20. MLST typing of antimicrobial-resistant Propionibacterium acnes isolates from patients with moderate to severe acne vulgaris.
Giannopoulos L; Papaparaskevas J; Refene E; Daikos G; Stavrianeas N; Tsakris A
Anaerobe; 2015 Feb; 31():50-4. PubMed ID: 25451716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
